Swire Eyes More Hospital Investment in China, Southeast Asia
- Group agrees to acquire control of DeltaHealth in Shanghai
- Co. looks to diversify into emerging sectors for growth
This article is for subscribers only.
After decades of operating Hong Kong’s marquee airline and coke bottling factories in China, Swire Pacific Ltd. is diversifying into a new line of business: private hospitals in China and Southeast Asia.
It has agreed in principal to acquire a controlling stake in DeltaHealth China Ltd., a hospital in Shanghai specializing in heart and vascular care. The purchase will mark the first health-care project where Swire leads the operation, as the Hong Kong-based conglomerate seeks to boost growth.